Summary Primary colorectal carcinomas of an unselected group of 159 patients 126 of whom could be curatively resected were examined for the expression of MHC class I antigens with monoclonal antibody W6/32 directed against a non-polymorphic determinant of HLA-A, B, C heavy chain. One hundred and nine (68.6%) were found to express HLA-A,B,C antigens in normal quantities, 33 (20.8%) showed a substantial reduction in expression, while 17 (10%) lacked these antigens either completely or incompletely. The loss of HLA-A, B, C was inversely correlated with the degree of differentiation. The tendency of mucinous carcinomas to lack class I antigens was statistically not significant. Tumours with distant metastatic spread at the time of operation tended to be normal with respect to HLA-A,B,C expression. Within the curatively resected group, poor differentiation and mucus production were risk factors for survival as could be shown by life table analysis after a maximum follow-up of 39 months. In contrast, the mode of HLA-A,B,C expression of the primary tumour did not influence survival within this time of observation. We conclude that in spite of increasing experimental data suggesting the contrary, the presence or absence of MHC class I antigens does not seem to profoundly modify tumour biology, at least in human colorectal carcinoma.
microglobulin, play an important role in the regulation of immune functions, as they are part of the target structures recognized by cytotoxic T-cells (Zinkernagel & Doherty, 1979) . HLA-A,B,C antigens are constitutively expressed on virtually all epithelial cells (Daar et al., 1984) and on B lymphocytes at all known stages of maturation (Brown et al., 1979) . It has been shown that malignant transformation of both cell types may be associated with changes in expression of class I products in the sense of reduction or complete loss (Fleming et al., 1981; Kabawat et al., 1983; Whitwell et al., 1984; Ferguson et al., 1985) . A pathological loss of HLA-A,B,C antigens in colorectal carcinoma was first reported by Daar et al. (1982) . We could recently show that in B-cell lymphomas defective expression of HLA-A, B, C is correlated with a high grade of malignancy (Moller et al., 1987) and that a loss or reduction of those antigens in colorectal carcinoma is inversely correlated with the grade of differentiation (Momburg et al., 1986) . Furthermore, recent data suggest an association of the mucinous type of colorectal adenocarcinoma, by itself an unfavourable prognostic parameter, with low expression of HLA class I antigens (van den Ingh et al., 1987) .
This study was undertaken to determine whether the defective HLA-A, B, C antigen expression on tumours which is believed to influence immune recognition of neoplastic cells has effects on important clinical aspects such as the ability to metastasize and survival. (Morson & Sobin, 1976; Dukes & Bussey, 1958; UICC, 1987) . The data are listed in Table I (Weber, 1980 (Weber, , 1982 . A Chi2 test was applied for the analysis of the contingency tables. The survival curves were calculated by the Kaplan/Meier method (Kaplan & Meier, 1958) . (Figure 4a ) although a curve was not obtained for grade I since only one death occurred in this cohort. A second parameter in terms of survival was the tumour type; patients with mucinous carcinomas were found to be prone to a shorter survival than the other group of non-mucinous tumour types taken together (Figure 4b ). No discriminating effect on survival, however, could be detected when attention was focussed on the three modes of HLA-A, B, C antigen expression. In fact the three resulting curves were very much alike in both the entire group and the curative resection group (Figure 4c ). In the attempt to narrow down further possible high-risk criteria, the HLA-A, B, C-antigen-negative tumour group was compared with the combination of normal and reduced antigen expression on the one hand, and the HLA-A, B, Cantigen-positive tumour group was compared to the joint group of reduced and (in)complete antigen expression on the other. However, neither setting proved to contribute to differences in survival.
Materials and methods

Patients
In summary, the reduction and (in)complete loss of HLA-A, B, C antigen expression in primary colon carcinoma, although highly correlated with the poorer grade of its histomorphological differentiation, did not prove to be a prognostic parameter for survival. 
Discussion
Our study aiming at the evaluation of HLA-A, B, C expression as a prognostic parameter is based upon an unselected group of colorectal cancer patients. With regard to its epidemiologic and pathological structure (Table I) , the cohort is comparable to those reported from Rochester (Moertel et al., 1986) , Edinburgh (Freedman et al., 1984) , London (Jass et al., 1986) , Padova (Corlon et al., 1984) and Sydney (Chapuis et al., 1985) . This is important to note in view of the reliability of our statements on HLA-A, B, C n . (Zinkernagel & Doherty, 1979) . It is therefore suggested that tumour cell variants with low or lacking class I antigen expression arise by immunoselection (Sanderson & Beverley, 1983) . Defects in class I antigen expression on tumour cells could offer growth advantages over other subpopulations with normal levels of expression (Gooding, 1982; Schmidt & Festenstein, 1982; Bernards et al., 1983) . In experimental tumour models, a reversal of tumourigenicity could be demonstrated after transfection of class I genes into cell lines which do not express the genes constitutively (Hui et al., 1984; Tanaka et al., 1985; Wallich et al., 1985) . Following this line of argument, tumours lacking class I antigens should be prone to take a more unfavourable clinical course as compared to those with normal expression. Although we are well aware that taking survival regardless of the cause of deaths as the only test parameter is a very stringent condition, our present data apparently fail to support this concept. It is even conceivable that the contrary may be true. Murine lymphoma cells selected for loss in class I antigen expression were found to be less malignant after inoculation in syngeneic hosts that were wild-type cells. The rejection of such cells was found to function via non-adaptive mechanisms (Karre et al., 1986) . Likewise, induction and/or enhancement of class I products of non-murine melanoma cells increased the number of metastases in inoculated animals; tumour cell elimination of class I antigen deficient cells was due to rapid triggering of natural killer cells (Taniguchi et al., 1985 (Taniguchi et al., , 1987 
